Talazoparib and Enzalutamide Combination Improves Survival in Some Patients With Prostate Cancer
February 12, 2025
February 12, 2025
ALEXANDRIA, Virginia, Feb. 12 [Category: Medical] -- The American Society of Clinical Oncology posted the following news release:
* * *
Talazoparib and Enzalutamide Combination Improves Survival in Some Patients With Prostate Cancer
ALEXANDRIA, Va. -- Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a combination of talazoparib and enzalutamide may live longer compared to patients treated with e . . .
* * *
Talazoparib and Enzalutamide Combination Improves Survival in Some Patients With Prostate Cancer
ALEXANDRIA, Va. -- Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a combination of talazoparib and enzalutamide may live longer compared to patients treated with e . . .